G. Koellner et al., CRYSTAL-STRUCTURE OF CALF SPLEEN PURINE NUCLEOSIDE PHOSPHORYLASE IN ACOMPLEX WITH HYPOXANTHINE AT 2.15 ANGSTROM RESOLUTION, Journal of Molecular Biology, 265(2), 1997, pp. 202-216
Trimeric calf spleen purine nucleoside phosphorylase has been complexe
d with hypoxanthine via phosphorolysis of inosine in the presence of p
hosphate. The resulting ''Michaelis'' complex (three hypoxanthine mole
cules per trimer), presumed to be formed under these conditions, cryst
allized in the cubic space group P2(1)3, with unit cell dimension a=94
.11 Angstrom and one monomer in the asymmetric crystal unit; the biolo
gically active trimer is located on the crystallographic 3-fold axis.
High-resolution X-ray diffraction data were collected using synchrotro
n radiation (EMBL outstation, Hamburg, c/o DESY). The crystal structur
e has been determined by molecular replacement and refined at 2.15 Ang
strom resolution to an X-value of 0.18. In the hypoxanthine binding si
te, a cis-peptide bond between Asn243 and Lys244 is observed. Side-cha
ins of Glu201 and Asn243, as well as one integral water molecule locat
ed in the base binding site, form hydrogen bonds with the hypoxanthine
N-1 H, N-7 H and O-6. A second water molecule links the base position
s N-3 and N-9 with an adjacent pocket, which presumably is the phospha
te-binding site. This pocket is filled completely by a cluster of six
water molecules. Hence all possible donor/acceptor-positions of hypoxa
nthine are saturated by hydrogen-bonding to protein side-chains or int
egral water molecules. Purine nucleoside phosphorylase isolated form h
uman tissues is a primary target for chemotherapeutic intervention, an
d the more stable calf enzyme has similar physico-chemical and kinetic
properties, as well as response to inhibitors. Hence the high-resolut
ion structure presented here may serve for design of inhibitors with p
otential pharmacological applications. (C) 1997 Academic Press Limited